Socioeconomic Status and Overall Survival Among Patients With Hematological Malignant Neoplasms
Authors:
Open Access
- 4 March 2024
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 7 (3) , e241112
Abstract
Socioeconomic status (SES), often measured by educational attainment or income level, is known to impact the course and outcome of cancers.1 In countries with tax-funded health care schemes, outcome differences associated with nonbiological factors, such as SES, could indicate unintended barriers in access to health care services. Understanding the mechanisms behind differences in outcome is important to reduce inequality and because differences might reveal opportunities for improvement that could benefit all patients.Keywords
This publication has 44 references indexed in Scilit:
- Relapse surveillance of acute myeloid leukemia patients in first remission after consolidation chemotherapy: diagnostic value of regular bone marrow aspirationsAnnals of Hematology, 2022
- The prognostic impact of anthropometrics in acute myeloid leukemia treated with intensive chemotherapy – A Danish nationwide cohort studyLeukemia Research, 2021
- Differences in survival among multiple myeloma patients in the United States SEER population by neighborhood socioeconomic status and race/ethnicityCancer Causes & Control, 2021
- Socioeconomic deprivation is associated with decreased survival in patients with acute myeloid leukemiaCancer Epidemiology, 2020
- Impact of time to antibiotic on hospital stay, intensive care unit admission, and mortality in febrile neutropeniaSupportive Care in Cancer, 2019
- Socioeconomic inequality in cancer survival – changes over time. A population-based study, Denmark, 1987–2013Acta Oncologica, 2019
- No outcome disparities in patients with diffuse large B-cell lymphoma and a low socioeconomic statusCancer Epidemiology, 2017
- US trends in survival disparities among adolescents and young adults with non-Hodgkin lymphomaCancer Causes & Control, 2015
- Socioeconomic position, treatment, and survival of non-Hodgkin lymphoma in Denmark – a nationwide studyBritish Journal of Cancer, 2012
- A Predictive Model for Aggressive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993